3rd Quarter - Report

FEDERAL HEALTH POLICY STRATEGIES for FRESENIUS MEDICAL CARE NORTH AMERICA

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to CY 2022 CMS End Stage Renal Disease Prospective Payment System Proposed Rule H.R. 5376, Build Back Better Act

Foreign entity interest: Fresenius Medical Care AG, identified on form LD-1, has an interest in the activities of its U.S. subsidiary Fresenius Medical Care North America on all issues

LobbyistCovered position, as disclosed
DAN ELLING —
COOKAB HASHEMI —
COLIN ROSKEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5376 (117th)

Health Issues HCR

Issues related to CY 2022 CMS End Stage Renal Disease Prospective Payment System Proposed Rule H.R. 5376, Build Back Better Act

Foreign entity interest: Fresenius Medical Care AG, identified on form LD-1, has an interest in the activities of its U.S. subsidiary Fresenius Medical Care North America on all issues

LobbyistCovered position, as disclosed
DAN ELLING —
COOKAB HASHEMI —
COLIN ROSKEY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 5376 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.